Study #2023-0322
A phase 3, two-stage, randomized, multi-center, controlled, open-label study comparing Iberdomide maintenance to Lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM) (EXCALIBER-Maintenance)
MD Anderson Study Status
Enrolling
Treatment Agent
Iberdomide, Lenalidomide
Description
The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Multiple Myeloma
Study phase:
Phase III
Physician name:
Oren Pasvolsky
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-844-933-0254
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.